Aptevo Reports 21% of Frontline AML Patients Reach Stem Cell Transplant
Aptevo said 21% of frontline acute myeloid leukemia patients reached stem cell transplant after mipletamig combination therapy.
Aptevo said 21% of frontline acute myeloid leukemia patients reached stem cell transplant after mipletamig combination therapy.